Jazz Pharmaceuticals plc logo
Jazz Pharmaceuticals plc JAZZ
€ 163.33 0.23%

Geschäftsbericht 2025
hinzugefügt 24.02.2026

report update icon

Jazz Pharmaceuticals plc Finanzkreislauf 2011-2026 | JAZZ

Finanzkreislauf Jährlich Jazz Pharmaceuticals plc

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
66.2 63.8 64.6 60.6 56.6 58.1 149 88 113 98 49.6 73.2 79.7 96.4 14.6

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
149 14.6 75.4

Finanzkreislauf Vierteljährlich Jazz Pharmaceuticals plc

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
59.9 59.6 70 61.5 62.6 67.5 58.1 58.8 65.2 - 29.2 28 63.7 - 54.8 55.9 60.9 54.4 60.2 64.3 64.2 55.8 60.4 60.8 55.6 50.5 51.3 48.1 50.1 46.9 49.7 51.9 55.6 53.9 57.1 56.1 60.3 56.1 56.1 57.3 58.4 51.8 55.5 58.4 57.5 48.3 49 54.7 46.6 37.5 39.2 55.4 48.9 37.5 42.8 48.6 -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
70 28 54.1

Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler

Name Finanzkreislauf Preis % 24h Marktkapitalisierung Land
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
115 $ 20.7 -1.24 % $ 2.61 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-400 $ 0.84 7.59 % $ 4.58 M chinaChina
Axsome Therapeutics Axsome Therapeutics
AXSM
-256 $ 166.38 1.52 % $ 8.28 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
173 $ 3.82 5.82 % $ 1.14 B canadaCanada
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
Codexis Codexis
CDXS
-48.2 $ 1.02 0.99 % $ 74.9 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Cellectis S.A. Cellectis S.A.
CLLS
-839 $ 3.8 -2.06 % $ 116 M franceFrance
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
117 - -24.86 % $ 820 K usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
537 $ 41.6 -0.17 % $ 1.32 B usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
-402 $ 35.97 0.76 % $ 3.74 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
120 $ 23.88 3.47 % $ 2.92 B usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
Curis Curis
CRIS
103 $ 1.08 -5.26 % $ 6.81 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
-4.27 K $ 40.68 -1.02 % $ 3.83 B usaUSA
Champions Oncology Champions Oncology
CSBR
1.94 $ 6.07 2.71 % $ 82.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
DBV Technologies S.A. DBV Technologies S.A.
DBVT
71.3 $ 23.25 10.77 % $ 2.26 B franceFrance
AgeX Therapeutics AgeX Therapeutics
AGE
-8.96 K - -10.17 % $ 12.2 K usaUSA
Precision BioSciences Precision BioSciences
DTIL
6.07 $ 4.33 3.1 % $ 16.6 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Agenus Agenus
AGEN
-6 K $ 3.34 0.3 % $ 1.2 M usaUSA
Dyadic International Dyadic International
DYAI
-128 $ 0.77 -1.68 % $ 22.2 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
Editas Medicine Editas Medicine
EDIT
149 $ 2.15 -2.27 % $ 177 M usaUSA
Edesa Biotech Edesa Biotech
EDSA
97.1 $ 2.28 3.64 % $ 7.29 M usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
735 $ 29.2 -3.41 % $ 1.69 B usaUSA
Advaxis Advaxis
ADXS
-143 K - -9.65 % $ 45.9 M usaUSA
Equillium Equillium
EQ
33.2 $ 1.92 5.49 % $ 66.7 M usaUSA